• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AI Predicts Medication Prescribing Patterns for Children With Neurodevelopmental Conditions

by
November 8, 2026
in Health
Reading Time: 2 mins read
0
AI Predicts Medication Prescribing Patterns for Children With Neurodevelopmental Conditions

AI Predicts Medication Prescribing Patterns for Children With Neurodevelopmental Conditions

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Artificial intelligence models can accurately learn expert prescribing patterns and predict medication decisions for children with neurodevelopmental conditions, according to a multi-cohort study. Researchers developed and validated machine learning tools designed to predict prescribing decisions across three major drug classes: stimulants, anti-depressants, and anti-psychotics.

The study addressed ongoing challenges in pediatric neurodevelopmental healthcare, where psychotropic medications are frequently prescribed but patient responses vary widely. Prescribing practices in this field remain largely off-label, and the specialized clinical expertise needed to guide complex pharmacological treatment is heavily concentrated in dedicated regional programs.

To establish initial model feasibility within research cohorts, investigators trained algorithms to predict cross-sectional medication use from the Child Behaviour Checklist. Model development and internal testing were conducted using data from 598 participants in the Province of Ontario Neurodevelopmental network. External generalizability was then evaluated across two independent datasets: the Healthy Brain Network study, comprising 1,764 participants, and the Adolescent Brain Cognitive Development study, comprising 2,396 participants.

During internal testing across the research cohorts, the artificial intelligence models achieved a median area under the receiver operating characteristic curve of 0.75 (interquartile range: 0.73 to 0.80) for stimulants, 0.83 (interquartile range: 0.78 to 0.87) for anti-depressants, and 0.79 (interquartile range: 0.72 to 0.86) for anti-psychotics. External testing across the independent cohorts confirmed the generalizability of these predictions.

Clinical evaluation was conducted using electronic medical records from 312 patients in the Psychopharmacology Program at Holland Bloorview Kids Rehabilitation Hospital to predict the medication class prescribed at a follow-up visit approximately three months later. In this real-world clinical cohort, the models achieved a median area under the curve of 0.84 (interquartile range: 0.81 to 0.88) for stimulants, 0.82 (interquartile range: 0.77 to 0.87) for anti-depressants, and 0.87 (interquartile range: 0.83 to 0.91) for anti-psychotics.

The researchers noted that the modelled outcome across all cohorts was the clinician’s prescribing decision rather than a direct measurement of treatment response or clinical benefit. These prescribing decisions incorporate clinician judgement, family preference, medication tolerability, and access to care alongside expected effectiveness, supporting the potential of data-driven tools to assist personalized medication management.

The findings were shared early as accepted, peer-reviewed research carrying a permanent digital object identifier ahead of the final Version of Record.

Subject of Research: Artificial intelligence models predicting psychotropic medication prescribing in neurodevelopmental conditions

Article Title: A precision health approach to medication management in neurodevelopmental conditions: a model development and validation study using four international cohorts

Article References: Vandewouw, M. M., Niroomand, K., Bokadia, H., Lenz, S., Rapley, J., Arias, A., Crosbie, J., Trinari, E., Kelley, E., Nicolson, R., Schachar, R. J., Arnold, P. D., Iaboni, A., Lerch, J. P., Penner, M., Baribeau, D., Anagnostou, E., & Kushki, A. (2026). A precision health approach to medication management in neurodevelopmental conditions: a model development and validation study using four international cohorts. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04541-1

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04541-1

Keywords: Artificial Intelligence, Neurodevelopmental Conditions, Psychopharmacology, Pediatric Health, Stimulants, Antidepressants, Antipsychotics, Precision Health, precision, health, approach, medication

News Source: Glenn Wilkins. (November 8, 2026). AI Predicts Medication Prescribing Patterns for Children With Neurodevelopmental Conditions. Scienmag.

Tags: antidepressantsantipsychoticsapproachArtificial IntelligencehealthMedicationneurodevelopmental conditionspediatric healthprecisionPrecision Healthpsychopharmacologystimulants
Share12Tweet7Share2ShareShareShare1

Related Posts

Neonatal Acute Kidney Injury Rates Reach Thirty Percent in Recent Studies

Neonatal Acute Kidney Injury Rates Reach Thirty Percent in Recent Studies

November 18, 2026
Young Schoolchildren Rapidly Develop Robotic Surgery Skills on Portable Virtual Reality Simulator

Young Schoolchildren Rapidly Develop Robotic Surgery Skills on Portable Virtual Reality Simulator

November 18, 2026

Mass Net Distribution Expands Household Malaria Protection in Papua New Guinea

November 18, 2026

STING Hyperactivation Suppresses JAK-STAT Signaling in Aging People Living With HIV

November 18, 2026

POPULAR NEWS

  • Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Motor Imagery Vividness Shows No Link to Parkinson’s Motor Symptom Severity

    29 shares
    Share 12 Tweet 7
  • Brain Tumour Review Identifies Ferroptosis Checkpoints and Spatial Therapeutic Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Hepatitis C Vesicles Maintain Immunosuppressive Signals Despite Antiviral Cure in Cirrhosis

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neonatal Acute Kidney Injury Rates Reach Thirty Percent in Recent Studies

Young Schoolchildren Rapidly Develop Robotic Surgery Skills on Portable Virtual Reality Simulator

Mass Net Distribution Expands Household Malaria Protection in Papua New Guinea

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.